- Home
- SNY vs MMC Comparison
SNY vs MMC Comparison
Compare SNY & MMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNY | MMC |
|---|---|---|
| Founded | 1994 | 1871 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.4B | 103.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SNY | MMC |
|---|---|---|
| Price | $49.34 | $181.87 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 15 |
| Target Price | $61.50 | ★ $220.07 |
| AVG Volume (30 Days) | 2.3M | ★ 2.6M |
| Earning Date | 10-24-2025 | 10-16-2025 |
| Dividend Yield | ★ 3.23% | 1.98% |
| EPS Growth | ★ 105.93 | 2.86 |
| EPS | ★ 8.67 | 8.34 |
| Revenue | ★ $53,890,648,839.00 | $26,453,000,000.00 |
| Revenue This Year | $2.37 | $11.29 |
| Revenue Next Year | $6.51 | $5.01 |
| P/E Ratio | ★ $11.25 | $21.80 |
| Revenue Growth | N/A | ★ 10.47 |
| 52 Week Low | $44.62 | $174.18 |
| 52 Week High | $60.12 | $248.00 |
Technical Indicators
Market Signals| Indicator | SNY | MMC |
|---|---|---|
| Relative Strength Index (RSI) | 46.53 | 45.49 |
| Support Level | $48.89 | $181.87 |
| Resistance Level | $50.43 | $185.05 |
| Average True Range (ATR) | 0.73 | 2.80 |
| MACD | -0.15 | 0.78 |
| Stochastic Oscillator | 19.29 | 58.65 |
Price Performance
Historical ComparisonAbout SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About MMC Marsh & McLennan Companies Inc.
Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.